¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"intercapillary nephrosclerosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intercapillary glomerulonephritis
    ¸ð¼¼°ü»çÀÌÅ丮ÄáÆÏ¿°, ¸ð¼¼°ü°£»ç±¸Ã¼½Å¿°
  • intercapillary glomerulosclerosis
    ¸ð¼¼°ü»çÀÌÅ丮±»À½Áõ, ¸ð¼¼°ü°£»ç±¸Ã¼°æÈ­Áõ
  • arterial nephrosclerosis
    µ¿¸ÆÄáÆÏ±»À½(Áõ), µ¿¸Æ½Å°æÈ­(Áõ)
  • arteriosclerotic nephrosclerosis
    µ¿¸Æ°æÈ­ÄáÆÏ±»À½(Áõ), µ¿¸Æ°æÈ­½Å°æÈ­(Áõ)
  • hypertensive nephrosclerosis
    °íÇ÷¾ÐÄáÆÏ±»À½(Áõ), °íÇ÷¾Ð½Å°æÈ­(Áõ)
  • nephrosclerosis
    ÄáÆÏ±»À½(Áõ), ½ÅÀå°æÈ­(Áõ)
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrosclerosis
    ÄáÆÏ±»À½Áõ, ½ÅÀå°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • intercapillary glomerulonephritis
    ¸ð¼¼°üÅ丮ÄáÆÏ¿°, ¸ð¼¼°ü°£»ç±¸Ã¼½Å¿°
  • intercapillary glomerulosclerosis
    ¸ð¼¼°üÅ丮±»À½Áõ, ¸ð¼¼°ü°£»ç±¸Ã¼°æÈ­Áõ
  • arterial nephrosclerosis
    µ¿¸ÆÄáÆÏ±»À½Áõ
  • arteriosclerotic nephrosclerosis
    µ¿¸Æ°æÈ­ÄáÆÏ±»À½Áõ
  • hypertensive nephrosclerosis
    °íÇ÷¾ÐÄáÆÏ±»À½Áõ
  • nephrosclerosis
    ÄáÆÏ±»À½Áõ, ½ÅÀå°æÈ­Áõ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulosclerosis,intercapillary
    ¸ð¼¼Ç÷°ü»çÀÌ
  • arterial nephrosclerosis
    µ¿¸Æ¼º ½Å°æÈ­Áõ.
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • hypertensive nephrosclerosis
    °íÇ÷¾Ð¼º ½Å°æÈ­(Áõ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • glomerulosclerosis,intercapillary
    ¸ð¼¼Ç÷°ü»çÀÌ
  • intercapillary cell
    ¸ð¼¼(Ç÷)°ü°£¼¼Æ÷.
  • intercapillary glomerulonephritis
    ¸ð¼¼(Ç÷)°ü°£»ç±¸Ã¼½Å¿°.
  • intercapillary glomerulosclerosis
    ¸ð¼¼(Ç÷)°ü°£»ç±¸Ã¼°æÈ­Áõ.
  • arterial nephrosclerosis
    µ¿¸Æ¼º ½Å°æÈ­Áõ.
  • arteriosclerotic nephrosclerosis
    µ¿¸Æ°æÈ­¼º ½Å°æÈ­Áõ(¡­ãìÌãûùñø).
  • benign nephrosclerosis
    ¾ç¼º½Å°æÈ­Áõ(¡­ãìÌãûùñø).
  • hypertension,benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
  • hypertensive nephrosclerosis
    °íÇ÷¾Ð¼º ½Å°æÈ­(Áõ).
  • malignant nephrosclerosis
    ¾Ç¼º½Å°æÈ­Áõ(ç÷àõãìÌãûùñø).
  • malignant nephrosclerosis
    ¾Ç¼º½Å°æÈ­Áõ(ç÷àõãìÌãûùñø)
  • nephrosclerosis
    ½Å°æÈ­
  • nephrosclerosis
    ½Å°æÈ­Áõ(¡­Ìãûùñø)
  • nephrosclerosis =sclerotic kidney
    ½Å°æÈ­(Áõ)(ãìÌãûùñø)
  • toxic nephrosclerosis
    Áßµ¶¼º½Å°æÈ­Áõ(¡­ãìÌãûùñø)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • nephrosclerosis
    ½Å°æÈ­(Áõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
BNS benign nephrosclerosis
MN a blood group in the MNSs blood group system; malignant nephrosclerosis; Master of Nursing; meganewt...
NS natural science; Neosporin; nephrosclerosis; nephrotic syndrome; nervous system; neurological surger...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
ICD Intercapillary distance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • benign nephrosclerosis
    ¾ç¼º ½Å°æÈ­Áõ
    °íÇ÷¾ÐÀÇ ¾ç¼º ±â¿¡ ³ªÅ¸³ª´Â ½ÅÀå º¯È­¸¦ ³ªÅ¸³»´Â ¿ë¾î. ¼¼µ¿¸Æ¿¡¼­ À¯¸®¾ç °æÈ­ÁõÀ» º¸ÀÌ°í ºñ·Ï ¹Ì¾àÇÏÁö¸¸ ¾î´À Á¤µµÀÇ ¾ç¼º ½Å °æÈ­ÁõÀº 60¼¼ ÀÌ»óÀÇ ºÎ°Ë ½Ã ÀÚÁÖ °üÂûÇÒ ¼ö ÀÖ´Ù. Ç÷¾ÐÀÌ Á¤»óÀÎ »ç¶÷¿¡¼­µµ °íÇ÷¾ÐÀ̳ª ´ç´¢º´ÀÌ ÀÖ´Â °æ¿ì´Â ´õ¿í ºó¹øÇÏ°í ½ÉÇÑ º´º¯À» º¼ ¼ö ÀÖ´Ù. ½ÅÀåÀÇ Å©±â´Â Á¤»óÀ̰ųª ÁÙ¾îµé ¼ö ÀÖÀ¸¸ç Ç¥¸é¿¡ ÀÛÀº °ú¸³¼ºÀÇ ÇÔ¸ôµÈ Ç¥¸éÀÌ °üÂûµÈ´Ù. ½ÅÀå ±â´ÉÀÇ ÀúÇϳª ´¢µ¶ÁõÀº ÃÊ·¡ÇÏÁö ¾ÊÀ¸¸ç ÀϹÝÀûÀ¸·Î ½Å Ç÷·ù·®ÀÇ °¨¼Ò´Â ÀÖ´Ù. ±×·¯³ª GFRÀº °¨¼ÒÇÏÁö ¾Ê°í °æ¹ÌÇÑ ´Ü¹é´¢´Â ÀÖÀ» ¼ö ÀÖ´Ù. Àå±â°£ Áö¼ÓµÈ ¾ç¼º °íÇ÷¾Ð ȯÀÚÀÇ ¾à 5% À̳»¿¡¼­ ½ÅºÎÀüÀÌ ¿Ã ¼ö Àִµ¥ ´ëºÎºÐÀÌ °íÇ÷¾ÐÀÇ accelerated
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
intercapillary Between or among capillary vessels.
(05 Mar 2000)
intercapillary cell <pathology> Cells found within the glomerular lobules of mammalian kidney, where they serve as structural supports, may regulate blood flow, are phagocytic and may act as accessory cells, presenting antigen in immune responses.
(18 Nov 1997)
intercapillary glomerulosclerosis Kidney disease and resultant kidney function impairment due to the long standing effects of diabetes on the microvasculature (glomerulus) of the kidney. Features include increased urine protein and declining kidney function. Severe diabetic nephropathy can lead to kidney failure and end-stage renal disease.
(27 Sep 1997)
arterial nephrosclerosis Patchy atrophic scarring of the kidney due to arteriosclerotic narrowing of the lumens of large branches of the renal artery, occurring in old or hypertensive persons and occasionally causing hypertension.
Synonym: arterionephrosclerosis, senile nephrosclerosis.
(05 Mar 2000)
arteriolar nephrosclerosis <nephrology> Refers to the destructive changes that occur in the blood vessels of the kidney due to severe hypertension (malignant hypertension). Prolonged hypertension can result in renal failure.
(17 Oct 1997)
benign nephrosclerosis <nephrology> Refers to the destructive changes that occur in the blood vessels of the kidney due to severe hypertension (malignant hypertension). Prolonged hypertension can result in renal failure.
(17 Oct 1997)
malignant nephrosclerosis The renal changes in malignant hypertension; subcapsular petechiae, necrosis in the walls of scattered afferent glomerular arterioles, and red blood cells and casts in the urine, with uraemia as a common termination.
(05 Mar 2000)
senile nephrosclerosis Patchy atrophic scarring of the kidney due to arteriosclerotic narrowing of the lumens of large branches of the renal artery, occurring in old or hypertensive persons and occasionally causing hypertension.
Synonym: arterionephrosclerosis, senile nephrosclerosis.
(05 Mar 2000)
nephrosclerosis Hardening (sclerosis) of the kidney usually due to disease of the blood vessels in it from atherosclerosis.
(12 Dec 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á